A Review on Revolutionizing Healthcare Technologies with AI and ML Applications in Pharmaceutical Sciences

A Review on Revolutionizing Healthcare Technologies with AI and ML Applications in Pharmaceutical Sciences

Background/Objectives: The integration of Artificial Intelligence (AI) and Machine Learning (ML) in pharmaceutical research and development is transforming the industry by improving efficiency and effectiveness across drug discovery, development, and healthcare delivery. This review explores the div...

Full description

Saved in:

Bibliographic Details
Main Authors:	Priyanka Kandhare, Mrunal Kurlekar, Tanvi Deshpande, Atmaram Pawar
Format:	Article
Language:	English
Published:	MDPI AG 2025-03-01
Series:	Drugs and Drug Candidates
Subjects:	artificial intelligence machine learning chemoinformatics QSAR modeling molecular docking biomarker discovery
Online Access:	https://www.mdpi.com/2813-2998/4/1/9
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Bioactive Xanthone C-glycoside Derivatives – QSAR Approach
by: V. N. Aksenova, et al.
Published: (2023-05-01)

From molecules to data: the emerging impact of chemoinformatics in chemistry
by: Anup Basnet Chetry, et al.
Published: (2025-08-01)

Theoretical–Cheminformatic Study of Four Indolylphytoquinones, Prospective Anticancer Candidates
by: Edgar Daniel Moyers-Montoya, et al.
Published: (2024-11-01)

Higher education in chemoinformatics: achievements and challenges
by: Alexandre Varnek, et al.
Published: (2025-05-01)

Design, synthesis, and screening of an RNA optimized fluorinated fragment library
by: Kasper P. Lundquist, et al.
Published: (2025-03-01)

ML enhanced bioactivity prediction for angiotensin II receptor: A potential anti-hypertensive drug target
by: Jeyanthi Sankar, et al.
Published: (2025-07-01)

5-(2-Carboxyethenyl)-Isatin Derivatives as Anticancer Agents: QSAR, Molecular Docking and Molecular Dynamic Simulation Analysis
by: Leila Emami, et al.
Published: (2021-05-01)

Drug design of an anticancer drug: QSAR modeling, and molecular docking
by: Sedigheh Aghayari
Published: (2025-09-01)

Benchmarking molecular conformer augmentation with context-enriched training: graph-based transformer versus GNN models
by: Cecile Valsecchi, et al.
Published: (2025-05-01)

Discovering New Tyrosinase Inhibitors by Using In Silico Modelling, Molecular Docking, and Molecular Dynamics
by: Kevin A. OréMaldonado, et al.
Published: (2025-03-01)

In silico modeling and experimental validation of 2-oxoimidazolidin-4-sulfonamides as low-toxicity fungicides against Phytophthora infestans
by: Vasyl Kovalishyn, et al.
Published: (2025-06-01)

Tracking protein kinase targeting advances: integrating QSAR into machine learning for kinase-targeted drug discovery
by: Rand Shahin, et al.
Published: (2025-12-01)

NeSyDPP-4: discovering DPP-4 inhibitors for diabetes treatment with a neuro-symbolic AI approach
by: Delower Hossain, et al.
Published: (2025-07-01)

Halogenated 2,4-diphenyl indeno[1,2-B]pyridinol derivatives as potential inhibitors of the androgen receptor (PDB ID: 58TE): A study of QSAR modeling, molecular docking, and pharmacokinetics for prostate cancer treatment
by: Auwal Salisu Isa, et al.
Published: (2024-09-01)

Cheminformatics approaches to predict the bioactivity and to discover the pharmacophoric traits crucial to block NF-κB
by: Rahul D. Jawarkar, et al.
Published: (2024-12-01)

SMILES-based QSAR and molecular docking studies of chalcone analogues as potential anti-colon cancer
by: Abolfazl Askarzade, et al.
Published: (2025-02-01)

Publishing neural networks in drug discovery might compromise training data privacy
by: Fabian P. Krüger, et al.
Published: (2025-03-01)

Cutting-edge AI tools revolutionizing scientific research in life sciences
by: Katarzyna Lorenc-Kukula
Published: (2025-03-01)

Exploring QSAR, molecular docking, molecular dynamics and pharmacokinetics for 3,4-Dihydro-2H,6H-pyrimido[1,2-c][1,3]benzothiazin-6-imine derivatives targeting Plasmodium falciparum dihydroorotate dehydrogenase
by: Naveen Dhingra, et al.
Published: (2025-05-01)

Integrating QSAR modelling with reinforcement learning for Syk inhibitor discovery
by: Maria Zavadskaya, et al.
Published: (2025-04-01)

In silico design of novel pyridazine derivatives as balanced multifunctional agents against Alzheimer’s disease
by: Mourad Aloui, et al.
Published: (2025-05-01)

2D-QSAR driven design, molecular docking, molecular dynamics simulation and MM/GBSA studies on quinazoline derivatives for development of VEGFR-2 inhibitors
by: Mayank Kashyap, et al.
Published: (2025-05-01)

In silico design of novel dihydropteridone derivatives with oxadiazoles as potent inhibitors of MCF-7 breast cancer cells
by: Mourad Aloui, et al.
Published: (2025-07-01)

Harnessing the Power of Machine Learning Guided Discovery of NLRP3 Inhibitors Towards the Effective Treatment of Rheumatoid Arthritis
by: Sidra Ilyas, et al.
Published: (2024-12-01)

The potential of Curcuma longa L. bioactive compounds as RSK inhibitors for the treatment of prostate cancer: in silico study
by: Olusola Olalekan Elekofehinti, et al.
Published: (2025-01-01)

Application of microneedle arrays in cosmetics: Promises, advances, and challenges
by: Amarjitsing Rajput, et al.
Published: (2024-12-01)

A new approach to atom-to-atom mapping using the naive Bayesian classifier
by: A.I. Khayrullina, et al.
Published: (2018-06-01)

An approach for automated detection of missing reagents and products in chemical reaction equations
by: R.I. Nugmanov, et al.
Published: (2018-03-01)

Identification of novel potential benzimidazole derivatives by pharmacophore generation, 3D-QSAR, virtual screening, molecular docking and ADME/ TOX analysis against breast cancer as targeted estrogen alpha receptor
by: Aastha Sharma, et al.
Published: (2025-04-01)

Synthesis and In Silico Evaluation of GABA, Pregabalin and Baclofen <i>N</i>-Heterocyclic Analogues as GABA<sub>B</sub> Receptor Agonists
by: Zuleyma Martínez-Campos, et al.
Published: (2025-03-01)

Exploring the anti-tumor mechanisms of thiourea-derived CXCR2 antagonists: a computational perspective
by: Khadija Zaki, et al.
Published: (2025-05-01)

Exploring novel furochochicine derivatives as promising JAK2 inhibitors in HeLa cells: Integrating docking, QSAR-ML, MD simulations, and experiments
by: Duangjai Todsaporn, et al.
Published: (2025-01-01)

Approaches to predict ligands affinity towards translocator protein TSPO 18 kDa in order to create molecules possessing neuropsychotropic activity
by: N. M. Baraboshkin, et al.
Published: (2019-01-01)

Revolutionizing pharmacology: AI-powered approaches in molecular modeling and ADMET prediction
by: Irfan Pathan, et al.
Published: (2025-12-01)

The Quest for Novel Cancer Biomarkers and Drug Targets in the Alternative Splicing Landscape
by: Abdullah Kahraman
Published: (2025-06-01)

The prospects for the use of vitamin B12 derivatives in pharmacology
by: I. Yu. Torshin, et al.
Published: (2023-11-01)

Chemoreactomic analysis of acyzole in comparison with zinc derivatives of nonsteroidal anti-inflammatory drugs
by: P. A. Galenko-Yaroshevsky, et al.
Published: (2024-05-01)

Enhancing the students’ perception of machine learning methods-based drug formulation using R_programming educational protocols
by: Rania M. Hathout, et al.
Published: (2025-08-01)

Py-CoMSIA: An Open-Source Implementation of Comparative Molecular Similarity Indices Analysis in Python
by: Christopher L. Haga, et al.
Published: (2025-03-01)

In Silico Screening Studies on Methanesulfonamide Derivatives as Dual Hsp27 and Tubulin Inhibitors Using QSAR and Molecular Docking
by: A. Mostoufi, et al.
Published: (2018-09-01)